Literature DB >> 15897265

Risk factors for adverse drug events: a 10-year analysis.

R Scott Evans1, James F Lloyd, Gregory J Stoddard, Jonathan R Nebeker, Matthew H Samore.   

Abstract

BACKGROUND: Many adverse drug events (ADEs) are the result of known pharmacologic properties, and some result from medication errors. However, some are the result of patient-specific risk factors.
OBJECTIVE: To identify inpatient risk factors for ADEs.
METHODS: Conditional logistic regression was used to analyze all pharmacist-verified ADEs by therapeutic class of drugs and severity during a 10-year study period. All inpatients > or = 18 years of age from a 520-bed tertiary teaching hospital were included. Each case patient was matched with up to 16 control patients. Odds ratios for patient factors associated with ADEs were calculated from different therapeutic classes of drugs.
RESULTS: Odds ratios for numerous risk factors were identified for 4376 ADEs and were found to vary depending on therapeutic classification. The risk factors for the different classifications were grouped by (1) patient characteristics--female (OR 1.5-1.7), age (0.7-0.9), weight (1.2-1.4), creatinine clearance (0.8-4.7), and number of comorbidities (1.1-12.6); (2) drug administration--dosage (1.2-3.7), administration route (1.4-149.9), and number of concomitant drugs (1.2-2.4); and (3) patient type--service (1.2-4.9), nursing division (1.5-3.8), and diagnosis-related group (1.5-5.7).
CONCLUSIONS: Some risk factors are consistent for all ADEs and across multiple therapeutic classes of drugs, while others are class specific. High-risk agents should be closely monitored based on patient characteristics (gender, age, weight, creatinine clearance, number of comorbidities) and drug administration (dosage, administration route, number of concomitant drugs).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15897265     DOI: 10.1345/aph.1E642

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  39 in total

1.  Risk factors for prescribing and transcribing medication errors among elderly patients during acute hospitalization: a cohort, case-control study.

Authors:  Arie Ben-Yehuda; Yitzchak Bitton; Pnina Sharon; Elena Rotfeld; Tikva Armon; Mordechai Muszkat
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

2.  Study of medication errors on a community hospital oncology ward.

Authors:  Clyde D Ford; Julie Killebrew; Penelope Fugitt; Janet Jacobsen; Elizabeth M Prystas
Journal:  J Oncol Pract       Date:  2006-07       Impact factor: 3.840

3.  Polypharmacy and adverse drug events among propensity score matched privately insured persons with and without spinal cord injury.

Authors:  Brittany N Hand; James S Krause; Kit N Simpson
Journal:  Spinal Cord       Date:  2018-01-23       Impact factor: 2.772

4.  Analysis of risk factors for adverse drug events in critically ill patients*.

Authors:  Sandra L Kane-Gill; Levent Kirisci; Margaret M Verrico; Jeffrey M Rothschild
Journal:  Crit Care Med       Date:  2012-03       Impact factor: 7.598

5.  Effects of learning climate and registered nurse staffing on medication errors.

Authors:  Yunkyung Chang; Barbara Mark
Journal:  Nurs Res       Date:  2011 Jan-Feb       Impact factor: 2.381

6.  Adverse drug events during AKI and its recovery.

Authors:  Zachary L Cox; Allison B McCoy; Michael E Matheny; Gautam Bhave; Neeraja B Peterson; Edward D Siew; Julia Lewis; Ioana Danciu; Aihua Bian; Ayumi Shintani; T Alp Ikizler; Erin B Neal; Josh F Peterson
Journal:  Clin J Am Soc Nephrol       Date:  2013-03-28       Impact factor: 8.237

7.  Self-reported medication side effects in an older cohort living independently in the community--the Melbourne Longitudinal Study on Healthy Ageing (MELSHA): cross-sectional analysis of prevalence and risk factors.

Authors:  Jennifer A Thomson; Wei C Wang; Colette Browning; Hal L Kendig
Journal:  BMC Geriatr       Date:  2010-06-10       Impact factor: 3.921

Review 8.  Inappropriate prescribing in the hospitalized elderly patient: defining the problem, evaluation tools, and possible solutions.

Authors:  Robert L Page; Sunny A Linnebur; Lucinda L Bryant; J Mark Ruscin
Journal:  Clin Interv Aging       Date:  2010-04-07       Impact factor: 4.458

9.  ESRD impairs nonrenal clearance of fexofenadine but not midazolam.

Authors:  Thomas D Nolin; Reginald F Frye; Phuong Le; Hooman Sadr; Judith Naud; Francois A Leblond; Vincent Pichette; Jonathan Himmelfarb
Journal:  J Am Soc Nephrol       Date:  2009-08-20       Impact factor: 10.121

10.  Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well?

Authors:  Amaia Calderón-Larrañaga; Beatriz Poblador-Plou; Francisca González-Rubio; Luis Andrés Gimeno-Feliu; José María Abad-Díez; Alexandra Prados-Torres
Journal:  Br J Gen Pract       Date:  2012-12       Impact factor: 5.386

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.